Bionik Laboratories Corp. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bionik Laboratories Corp. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Bionik Laboratories Corp. Return On Equity for the quarter ending March 31, 2023 was 46.2K %.
  • Bionik Laboratories Corp. annual Return On Equity for 2022 was -529 %, a 240% decline from 2021.
  • Bionik Laboratories Corp. annual Return On Equity for 2021 was -156 %, a 187% decline from 2020.
  • Bionik Laboratories Corp. annual Return On Equity for 2020 was -54.3 %, a 44.1% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -529 -373 -240% Apr 1, 2022 Mar 31, 2023
2021 -156 -101 -187% Apr 1, 2021 Mar 31, 2022
2020 -54.3 +42.9 +44.1% Apr 1, 2020 Mar 31, 2021
2019 -97.2 -46.7 -92.3% Apr 1, 2019 Mar 31, 2020
2018 -50.5 -111 -184% Apr 1, 2018 Mar 31, 2019
2017 60.1 +1.04K Apr 1, 2017 Mar 31, 2018
2016 -978 -387 -65.4% Apr 1, 2016 Mar 31, 2017
2015 -591 -583 -6876% Jan 1, 2015 Dec 31, 2015
2014 -8.47 -29.3 -141% Jan 1, 2014 Dec 31, 2014
2013 20.8 -2.13 -9.28% Jan 1, 2013 Dec 31, 2013
2012 23 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.